6.21
price down icon0.48%   -0.03
after-market Handel nachbörslich: 6.18 -0.03 -0.48%
loading

Neogenomics Inc Aktie (NEO) Neueste Nachrichten

pulisher
Jul 20, 2025

What analysts say about NeoGenomics Inc. stockUnmatched profit potential - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

What drives NeoGenomics Inc. stock priceRapidly expanding wealth - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

NeoGenomics Inc. Stock Analysis and ForecastDouble-digit growth - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Is NeoGenomics Inc. a good long term investmentBreakthrough wealth creation - Jammu Links News

Jul 19, 2025
pulisher
Jul 19, 2025

Personalized ctDNA monitoring in metastatic HR+/HER2− breast cancer patients during endocrine and CDK4/6 inhibitor therapy - Nature

Jul 19, 2025
pulisher
Jul 18, 2025

Neogenomics Shares Plunge 7.14% Amid Earnings Woes - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Moderna, Lantheus, Centene, AMN Healthcare Services, and NeoGenomics Shares Plummet, What You Need To Know - Yahoo Finance

Jul 18, 2025
pulisher
Jul 17, 2025

Pathological Examination Market Gaining Momentum in Cancer - openPR.com

Jul 17, 2025
pulisher
Jul 16, 2025

NeoGenomics (NASDAQ:NEO investor five-year losses grow to 81% as the stock sheds US$71m this past week - simplywall.st

Jul 16, 2025
pulisher
Jul 15, 2025

Why NeoGenomics Inc. stock attracts strong analyst attention200 Percent Profit Outlook - beatles.ru

Jul 15, 2025
pulisher
Jul 14, 2025

Q1 Earnings Highlights: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Testing & Diagnostics Services Stocks - Yahoo Finance

Jul 14, 2025
pulisher
Jul 11, 2025

NEO Stock Price and Chart — NASDAQ:NEO - TradingView

Jul 11, 2025
pulisher
Jul 11, 2025

NeoGenomics, RadNet, Pediatrix Medical Group, Penumbra, and Neogen Shares Plummet, What You Need To Know - Yahoo Finance

Jul 11, 2025
pulisher
Jul 10, 2025

Press Release: NeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025 - 富途牛牛

Jul 10, 2025
pulisher
Jul 05, 2025

NeoGenomics (NEO): A Contrarian Play on Turnaround and Undervaluation - AInvest

Jul 05, 2025
pulisher
Jul 05, 2025

The past five years for NeoGenomics (NASDAQ:NEO) investors has not been profitable - Yahoo Finance

Jul 05, 2025
pulisher
Jul 03, 2025

NeoGenomics Announces Chief Executive Officer Appointment - ACCESS Newswire

Jul 03, 2025
pulisher
Jul 02, 2025

Here’s Why NeoGenomics (NEO) Sold Off in Q1 - Insider Monkey

Jul 02, 2025
pulisher
Jul 02, 2025

NeoGenomics To Participate In Fireside Chat At Stephens 21st Annual Investment Conference - ACCESS Newswire

Jul 02, 2025
pulisher
Jul 01, 2025

NeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025 - Bluefield Daily Telegraph

Jul 01, 2025
pulisher
Jun 30, 2025

NeoGenomics Announces PanTracer Tissue and PanTracer Tissue + HRD Now Available to Support More Informed and Timely Cancer Care - The Joplin Globe

Jun 30, 2025
pulisher
Jun 24, 2025

5 Insightful Analyst Questions From NeoGenomics’s Q1 Earnings Call - Yahoo Finance

Jun 24, 2025
pulisher
Jun 18, 2025

NeoGenomics' Market Cap Drops To US$954m Leaving Insiders With Losses - simplywall.st

Jun 18, 2025
pulisher
Jun 18, 2025

NeoGenomics Requests to Dismiss Class Action Filed by Investors - TradingView

Jun 18, 2025
pulisher
Jun 18, 2025

NeoGenomics drops as sequential revenue decline leads to Q1 miss - MSN

Jun 18, 2025
pulisher
Jun 06, 2025

NeoGenomics Schedules its First Quarter 2021 Earnings Release for May 5, 2021 - ACCESS Newswire

Jun 06, 2025
pulisher
Jun 03, 2025

Investor Calendar Invites You to the NeoGenomics Fourth Quarter and Fiscal Year 2015 Earnings Conference Call and Webcast Live on Tuesday March 1, 2016 - ACCESS Newswire

Jun 03, 2025
pulisher
Jun 03, 2025

NeoGenomics at William Blair Conference: Strategic Growth and Innovation By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 03, 2025

NeoGenomics at William Blair Conference: Strategic Growth and Innovation - Investing.com Australia

Jun 03, 2025
pulisher
Jun 03, 2025

Where are the Opportunities in (NEO) - news.stocktradersdaily.com

Jun 03, 2025
pulisher
Jun 02, 2025

Cancer Tumor Profiling Market Rises with Demand - openPR.com

Jun 02, 2025
pulisher
Jun 02, 2025

Liquid Biopsy Market for Cancer Detection, cfDNA & CTC Analysis | - openPR.com

Jun 02, 2025
pulisher
May 29, 2025

Fort Myers-based NeoGenomics to unveil new cancer diagnostics at ASCO 2025 - Gulfshore Business

May 29, 2025
pulisher
May 29, 2025

NeoGenomics unveils new oncology diagnostics at ASCO 2025 By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 28, 2025

Neogenomics director Kelly buys $38,000 in common stock - Investing.com Australia

May 28, 2025
pulisher
May 28, 2025

Neogenomics director Kelly buys $38,000 in common stock By Investing.com - Investing.com Nigeria

May 28, 2025
pulisher
May 28, 2025

NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025 - BioSpace

May 28, 2025
pulisher
May 28, 2025

NeoGenomics unveils new oncology diagnostics at ASCO 2025 - Investing.com

May 28, 2025
pulisher
May 27, 2025

NeoGenomics Approves Key Proposals at Annual Meeting - TipRanks

May 27, 2025
pulisher
May 25, 2025

D. E. Shaw & Co. Inc. Trims Stock Position in NeoGenomics, Inc. (NASDAQ:NEO) - Defense World

May 25, 2025
pulisher
May 24, 2025

BNP Paribas Financial Markets Sells 35,979 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - Defense World

May 24, 2025
pulisher
May 24, 2025

NeoGenomics, Inc. (NASDAQ:NEO) Receives Average Rating of “Hold” from Analysts - Defense World

May 24, 2025
diagnostics_research WAT
$281.66
price down icon 2.04%
diagnostics_research DGX
$166.45
price down icon 0.28%
$140.63
price up icon 1.25%
diagnostics_research LH
$243.04
price down icon 0.28%
diagnostics_research MTD
$1,166.48
price down icon 2.37%
diagnostics_research IQV
$158.96
price down icon 1.04%
Kapitalisierung:     |  Volumen (24h):